255 related articles for article (PubMed ID: 10653869)
1. Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Société Française de Greffe de Moelle.
Blaise D; Kuentz M; Fortanier C; Bourhis JH; Milpied N; Sutton L; Jouet JP; Attal M; Bordigoni P; Cahn JY; Boiron JM; Schuller MP; Moatti JP; Michallet M
J Clin Oncol; 2000 Feb; 18(3):537-46. PubMed ID: 10653869
[TBL] [Abstract][Full Text] [Related]
2. Comparison of outcome of allogeneic bone marrow transplantation with and without granulocyte colony-stimulating factor (lenograstim) donor-marrow priming in patients with chronic myelogenous leukemia.
Ji SQ; Chen HR; Wang HX; Yan HM; Pan SP; Xun CQ
Biol Blood Marrow Transplant; 2002; 8(5):261-7. PubMed ID: 12064363
[TBL] [Abstract][Full Text] [Related]
3. Factors influencing the haematological recovery after allogeneic bone marrow transplantation in leukaemia patients treated with methotrexate-containing GVHD prophylaxis: a single-centre experience.
Hassan HT; Krog C; Stockschläder M; Schleimer B; Zeller W; Krüger W; Erttmann R; Zander AR
Anticancer Res; 1997; 17(1B):589-99. PubMed ID: 9066585
[TBL] [Abstract][Full Text] [Related]
4. T cell-depleted granulocyte colony-stimulating factor (G-CSF) modified allogenic bone marrow transplantation for hematological malignancy improves graft CD34+ cell content but is associated with delayed pancytopenia.
Mavroudis DA; Read EJ; Molldrem J; Raptis A; Plante M; Carter CS; Phang S; Dunbar CE; Barrett AJ
Bone Marrow Transplant; 1998 Mar; 21(5):431-40. PubMed ID: 9535034
[TBL] [Abstract][Full Text] [Related]
5. Combined transplantation of allogeneic bone marrow and CD34+ blood cells.
Link H; Arseniev L; Bähre O; Berenson RJ; Battmer K; Kadar JG; Jacobs R; Casper J; Kühl J; Schubert J; Diedrich H; Poliwoda H
Blood; 1995 Oct; 86(7):2500-8. PubMed ID: 7545459
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic bone marrow transplantation for chronic myeloid leukemia using HLA identical sibling donors primed with G-CSF.
Chen HR; Ji SQ; Wang HX; Yan HM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Aug; 10(4):340-6. PubMed ID: 12513770
[TBL] [Abstract][Full Text] [Related]
7. Donor leukocyte infusion for leukemic relapse after allogeneic marrow transplantation: lack of residual donor hematopoiesis predicts aplasia.
Keil F; Haas OA; Fritsch G; Kalhs P; Lechner K; Mannhalter C; Reiter E; Niederwieser D; Hoecker P; Greinix HT
Blood; 1997 May; 89(9):3113-7. PubMed ID: 9129013
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation.
Lemoli RM; Bandini G; Leopardi G; Rosti G; Bonini A; Fortuna A; Rondelli D; Mangianti S; Motta MR; Rizzi S; Tassi C; Cavo M; Remiddi C; Curti A; Conte R; Tura S
Haematologica; 1998 Jan; 83(1):48-55. PubMed ID: 9542323
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic blood stem cell and bone marrow transplantation for acute myelogenous leukemia and myelodysplasia: influence of stem cell source on outcome.
Russell JA; Larratt L; Brown C; Turner AR; Chaudhry A; Booth K; Woodman RC; Wolff J; Valentine K; Stewart D; Ruether JD; Ruether BA; Klassen J; Jones AR; Gyonyor E; Egeler M; Dunsmore J; Desai S; Coppes MJ; Bowen T; Anderson R; Poon MC
Bone Marrow Transplant; 1999 Dec; 24(11):1177-83. PubMed ID: 10642805
[TBL] [Abstract][Full Text] [Related]
10. Use of recombinant human granulocyte colony-stimulating factor in children given allogeneic bone marrow transplantation for acute or chronic leukemia.
Locatelli F; Pession A; Zecca M; Bonetti F; Prete L; Carrà AM; Prete A; Montagna D; Comoli P; Taibi RM; Paolucci G
Bone Marrow Transplant; 1996 Jan; 17(1):31-7. PubMed ID: 8673051
[TBL] [Abstract][Full Text] [Related]
11. Clinical and economic comparison of lenograstim-primed blood cells (BC) and bone marrow (BM) allogeneic transplantation.
Faucher C; Fortanier C; Viens P; Le Corroller AG; Chabannon C; Camerlo J; Novakovitch G; Gastaut JA; Maraninchi D; Moatti JP; Blaise D
Bone Marrow Transplant; 1998 Jun; 21 Suppl 3():S92-8. PubMed ID: 9712506
[TBL] [Abstract][Full Text] [Related]
12. Granulocyte colony-stimulating factor after allogeneic bone marrow transplantation.
Schriber JR; Chao NJ; Long GD; Negrin RS; Tierney DK; Kusnierz-Glaz C; Lucas KS; Blume KG
Blood; 1994 Sep; 84(5):1680-4. PubMed ID: 7520782
[TBL] [Abstract][Full Text] [Related]
13. Transplantation of allogeneic CD34+ blood cells.
Link H; Arseniev L; Bähre O; Kadar JG; Diedrich H; Poliwoda H
Blood; 1996 Jun; 87(11):4903-9. PubMed ID: 8639865
[TBL] [Abstract][Full Text] [Related]
14. Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxis.
Martin-Algarra S; Bishop MR; Tarantolo S; Cowles MK; Reed E; Anderson JR; Vose JM; Bierman P; Armitage JO; Kessinger A
Exp Hematol; 1995 Dec; 23(14):1503-8. PubMed ID: 8542938
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic peripheral blood stem cell transplantation results in less alteration of early T cell compartment homeostasis than bone marrow transplantation.
Tayebi H; Tiberghien P; Ferrand C; Lienard A; Duperrier A; Cahn JY; Lapierre V; Saas P; Kuentz M; Blaise D; Hervé P; Robinet E;
Bone Marrow Transplant; 2001 Jan; 27(2):167-75. PubMed ID: 11281386
[TBL] [Abstract][Full Text] [Related]
16. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies.
Cao TM; Kusnierz-Glaz C; Valone F; Stockerl-Goldstein KE; Hu WW; Johnston L; Blume KG; Strober S; Negrin RS
Cancer; 2001 Jun; 91(12):2205-13. PubMed ID: 11413507
[TBL] [Abstract][Full Text] [Related]
17. Granulocyte colony-stimulating factor-primed bone marrow: an excellent stem-cell source for transplantation in acute myelocytic leukemia and chronic myelocytic leukemia.
Li Y; Jiang M; Xu C; Chen J; Li B; Wang J; Hu J; Ning H; Chen H; Chen S; Hu L
Chin Med J (Engl); 2015 Jan; 128(1):20-4. PubMed ID: 25563308
[TBL] [Abstract][Full Text] [Related]
18. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Ringdén O; Labopin M; Gorin NC; Le Blanc K; Rocha V; Gluckman E; Reiffers J; Arcese W; Vossen JM; Jouet JP; Cordonnier C; Frassoni F
J Clin Oncol; 2004 Feb; 22(3):416-23. PubMed ID: 14691124
[TBL] [Abstract][Full Text] [Related]
19. Treatment of poor marrow graft function with allogeneic CD34+ cells immunoselected from G-CSF-mobilized peripheral blood progenitor cells of the marrow donor.
Arseniev L; Tischler HJ; Battmer K; Südmeier I; Casper J; Link H
Bone Marrow Transplant; 1994 Nov; 14(5):791-7. PubMed ID: 7534162
[TBL] [Abstract][Full Text] [Related]
20. Rapid engraftment after autologous transplantation utilizing marrow and recombinant granulocyte colony-stimulating factor-mobilized peripheral blood stem cells in patients with acute myelogenous leukemia.
Demirer T; Buckner CD; Appelbaum FR; Petersen FB; Rowley S; Weaver CH; Lilleby K; Sanders J; Chauncey T; Storb R
Bone Marrow Transplant; 1995 Jun; 15(6):915-22. PubMed ID: 7581091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
